Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats

Neuropharmacology

Volumn 39, Issue 3, 2000, Pages 497-506

  Wang, R H ^a   Bejar, C ^a   Weinstock, M ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Hippocampus; Orchidectomy; Ovariectomy; Physostigmine; Skeletal muscle; Spatial memory

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE; RIVASTIGMINE; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CHOLINESTERASE INHIBITION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HEART; HIPPOCAMPUS; MALE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PLASMA; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SKELETAL MUSCLE; SPATIAL MEMORY;

ANIMALS; BRAIN; CARBAMATES; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; FEMALE; MALE; MEMORY; MEMORY DISORDERS; MUSCARINIC ANTAGONISTS; MUSCLE, SKELETAL; MYOCARDIUM; ORCHIECTOMY; OVARIECTOMY; PHENYLCARBAMATES; PHYSOSTIGMINE; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE; SEX FACTORS;

EID: 0033955001     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00157-4     Document Type: Article

References (24)

1. Atack J.R., Perry E.K., Bonham J.R., Candy J.M., Perry R.H. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. Journal of Neurochemistry. 47:1986;263-277.
2. Barbarino A.S.M., Corsello A., Tofani R., Sciuto S., Della-Casa C.A., Rota A., Barini Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans. Journal of Clinical Endocrinology and Metabolism. 73:1991;75-78.
3. Cheng D.H., Tang X.C. Comparative studies of huperazine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol. Biochem. Behav. 60:1998;377-386.
4. Corey-Bloom J., Anand R., Veach J. For the ENA 713 B352 Study Group, 1998, A randomized trial evaluating efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. International Journal of Geriatric Psychopharmacology. 1:1998;55-65.
5. Cullumbine H. Actions at autonomic effector sites. Eichler O., Farah A., Koelle G.B. Handbuch Der Experimentellen Pharmakologie: Cholinesterases and Anticholinesterase Agents. 1963;515-516 Springer-Verlag, Berlin.
6. Du X.J., Dart A.M., Riemersma R.A. Sex differences in the parasympathetic nerve control of rat heart. Clinical and Experimental Pharmacology and Physiology. 21:1994;485-493.
7. Ellman G.L., Courtney K.D., Anders F., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
8. Enz A., Amstutz R., Bodekke H., Gmelin G., Malanowski J. Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Progress in Brain Research. 98:1993;431-438.
9. Farlow M.R., Hake A.M. Mechanism of action and metabolism of acetyl-cholinesterase inhibitors: implications for treatment. International Journal of Geriatric Psychopharmacology. 1(Suppl. 1):1998;s2-s6.
10. Farlow M.R., Lahiri D.K., Poirier J., Davignon J., Schneider L., Hui S.L. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subject with Alzheimer's disease. Neurology. 50:1998;669-677.
11. Giacobini E. From molecular structure to Alzheimer therapy. Japanese Journal of Pharmacology. 74:1997;225-241.
12. Hortnagl H., Hansen L., Kindel G., Schneider B., el-Tamer A., Hanin I. Sex differences and estrous cycle variations in the AF64A-induced cholinergic deficit in the rat hippocampus. Brain Research Bulletin. 31:1993;29-134.
13. Lapchak P.A., Araujo D.M., Quirion R., Beaudet A. Chronic estradiol treatment alters central cholinergic function in the female rat: effect on choline acetyltransferase activity, acetylcholine content, and nicotinic autoreceptor function. Brain Research. 525:1990;249-255.
14. Loy R., Sheldon R.A. Sexually dimorphic development of cholinergic enzymes in the rat septohippocampal system. Developments in Brain Research. 34:1987;156-160.
15. MacGowan S.H., Wilcock G.K., Scott M. Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease. International Journal of Geriatric Psychiatry. 13:1998;625-630.
16. Massoulie J., Pezzementi L., Bon S., Krejci E., Vallette F.-M. Molecular and cellular biology of cholinesterases. Progress in Neurobiology. 41:1993;31-91.
17. Morris R.G.M. An attempt to dissociate "spatial-mapping" and "working memory" theories of hippocampal function. Siefert W. The Neurobiology of the Hippocampus. 1983;405-432 Academic Press, London.
18. Morris R.G.M. Development of a water maze procedure for studying spatial learning in the rat. Journal of Neuroscientific Methods. 11:1984;47-60.
19. Peskind E.R., Raskind M.A., Wingerson D., Pascualy M., Thal L.J., Dobie D.J., Wilkinson C.W. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender. Biological Psychiatry. 40:1996;61-68.
20. Rumenjak V. Distribution of human erythrocyte acetylcholinesterase according to age, sex and pregnancy. Acta Med Croatica. 52:1998;187-189.
21. Singh S., Verma M., Leelamma C.O., Nain K., Goel R.C., Ganguly N.K., Sharma B.K. Red cell acetylcholinesterase and plasma cholinesterase activity and genetic variants of plasma cholinesterase in northwest Indian adults. International Journal of Clinical Pharmacology and Therapeutics. 35:1997;357-360.
22. Sung S.C., Ruff B.A. Molecular forms of sucrose extractable and particulate acetyl-cholinesterase in the developing and adult rat brain. Neurochemistry Research. 8:1983;303-311.
23. Tuovinen K., Kaliste-Korhonen E., Hanninen O. Gender differences in activities of mouse esterase and sensitivities to DFP and sarin toxicity. General Pharmacology. 29:1997;333-335.
24. Weinstock M., Razin M., Chorev M., Tashma Z. Pharmacological activity of novel anticholinesterase agents of potential use in the treatment of Alzheimer's disease. Adv. Behav. Biol. 29:1986;539-551.